
Penumbra PEN
$ 339.7
0.03%
Annual report 2025
added 02-25-2026
Penumbra P/CF Ratio 2011-2026 | PEN
Annual P/CF Ratio Penumbra
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 55.3 | 61.9 | 104 | -178 | 858 | -306 | 1.36 K | 254 | -1.43 K | -81.7 | -18.5 | -1.32 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.36 K | -1.43 K | 56.9 |
P/CF Ratio of other stocks in the Medical devices industry
| Issuer | P/CF Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Acutus Medical
AFIB
|
-0.083 | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
-0.98 | - | 3.58 % | $ 2.21 M | ||
|
Alphatec Holdings
ATEC
|
45.7 | $ 12.37 | -4.85 % | $ 1.86 B | ||
|
GenMark Diagnostics, Inc.
GNMK
|
-80.1 | - | - | $ 1.77 B | ||
|
Aziyo Biologics
AZYO
|
-1.24 | - | 1.37 % | $ 20.5 M | ||
|
Lianluo Smart Limited
LLIT
|
-62.7 | - | 24.59 % | $ 44.8 M | ||
|
Electromed
ELMD
|
15.3 | $ 24.26 | -0.12 % | $ 205 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
-3.31 | - | -5.86 % | $ 30.6 M | ||
|
Bruker Corporation
BRKR
|
0.000028 | $ 38.61 | 0.29 % | $ 5.75 K | ||
|
FONAR Corporation
FONR
|
5.57 | $ 18.59 | 0.32 % | $ 122 M | ||
|
Cognyte Software Ltd.
CGNT
|
14.1 | $ 8.29 | 1.22 % | $ 595 M | ||
|
Conformis
CFMS
|
-0.252 | - | - | $ 16.4 M | ||
|
AdaptHealth Corp.
AHCO
|
2 | $ 9.7 | 0.31 % | $ 1.31 B | ||
|
Apollo Endosurgery
APEN
|
-12.9 | - | - | $ 475 M | ||
|
Cardiovascular Systems
CSII
|
-24.2 | - | 0.15 % | $ 844 M | ||
|
CONMED Corporation
CNMD
|
7.72 | $ 41.54 | -3.37 % | $ 1.29 B | ||
|
EDAP TMS S.A.
EDAP
|
-4.42 | $ 4.19 | -1.41 % | $ 156 M | ||
|
Cutera
CUTR
|
-0.337 | - | -10.19 % | $ 1.99 M | ||
|
CryoLife, Inc.
CRY
|
180 | - | -4.14 % | $ 702 M | ||
|
Avinger
AVGR
|
-0.18 | - | -20.74 % | $ 369 K | ||
|
CHF Solutions, Inc.
CHFS
|
-0.0621 | - | 1.15 % | $ 34.5 M | ||
|
AxoGen
AXGN
|
1.84 K | $ 29.14 | -0.27 % | $ 1.34 B | ||
|
Apyx Medical Corporation
APYX
|
-8.71 | $ 3.26 | -1.21 % | $ 113 M | ||
|
Axonics Modulation Technologies
AXNX
|
885 | - | - | $ 3.31 B | ||
|
Dynatronics Corporation
DYNT
|
6.49 | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
-0.145 | - | - | $ 10.2 M | ||
|
Soliton, Inc.
SOLY
|
-18.5 | - | -1.42 % | $ 435 M | ||
|
Pulmonx Corporation
LUNG
|
-10.8 | $ 1.59 | 10.07 % | $ 62.2 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
-1.02 | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
-30.7 | - | 0.03 % | $ 1.58 B | ||
|
Second Sight Medical Products
EYES
|
-0.0108 | - | -0.97 % | $ 54.4 M | ||
|
Accuray Incorporated
ARAY
|
56.1 | $ 0.51 | -2.68 % | $ 52.4 M | ||
|
Misonix, Inc.
MSON
|
-6.81 | - | - | $ 462 M | ||
|
Medtronic PLC
MDT
|
15.8 | $ 92.77 | -2.97 % | $ 119 B | ||
|
Neovasc
NVCN
|
-25 | - | - | $ 111 M | ||
|
Cytosorbents Corporation
CTSO
|
-3.77 | $ 0.81 | 1.92 % | $ 44.1 M | ||
|
Align Technology
ALGN
|
18.9 | $ 174.88 | -4.0 % | $ 13.1 B | ||
|
Intersect ENT, Inc.
XENT
|
-20.1 | - | - | $ 955 M | ||
|
Butterfly Network
BFLY
|
-18.4 | $ 3.69 | -8.56 % | $ 781 M | ||
|
BIOLASE
BIOL
|
-0.0136 | - | -13.19 % | $ 166 K | ||
|
Abbott Laboratories
ABT
|
20.5 | $ 110.83 | -2.01 % | $ 193 B | ||
|
InMode Ltd.
INMD
|
10.9 | $ 13.48 | -0.57 % | $ 871 M | ||
|
Orthofix Medical
OFIX
|
14.7 | $ 12.56 | -2.41 % | $ 497 M | ||
|
BioSig Technologies
BSGM
|
-1.53 | - | 37.08 % | $ 85.7 M | ||
|
Boston Scientific Corporation
BSX
|
24.9 | $ 72.16 | -0.07 % | $ 107 B | ||
|
IRadimed Corporation
IRMD
|
26.1 | $ 99.47 | -5.37 % | $ 1.26 B | ||
|
Insulet Corporation
PODD
|
31.9 | $ 239.77 | -1.29 % | $ 16.9 B | ||
|
Profound Medical Corp.
PROF
|
-10.3 | - | - | $ 180 M | ||
|
IRIDEX Corporation
IRIX
|
-7.13 | $ 1.4 | -0.71 % | $ 22.6 M | ||
|
OrthoPediatrics Corp.
KIDS
|
-90 | $ 17.63 | -4.6 % | $ 414 M |